Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry
ConclusionDirect-acting antiviral therapies were well tolerated in patients older than 70 years. SVR12 rates in the elderly patient group were similar to those observed in younger patients. Differences in the prevalence of comorbidities between age groups warrant individualized attention with respect to drug–drug interactions and therapy adherence.The study was registered in the German Clinical Trials Register, DRKS-ID: DRKS00009717.
Source: Drugs and Aging - Category: Geriatrics Source Type: research
More News: Clinical Trials | Diabetes | Endocrinology | Epidemiology | Germany Health | Hepatitis | Hepatitis C | Psychiatry | Study | Substance Abuse | Substance Abuse Disorders